Treatment of recurrent giant cell tumor of bones: a systematic review

C Pitsilos, P Givissis, P Papadopoulos, B Chalidis - Cancers, 2023 - mdpi.com
Simple Summary There is limited evidence in the current literature about the best
management of the recurrent giant cell tumor of bones (GCTB). The aim of this systematic …

Diaphyseal giant cell tumor with multiple relapses in a skeletally immature patient: a case report

I El Shamly, O Kubwimana, T Habanabakize… - Pan African Medical …, 2022 - ajol.info
Giant cell tumor (GCT) is an aggressive osteolytic lesion mostly affecting the meta-epiphyses
of long bones at skeletal maturity. Occurrence of the GCT in diaphysis is a rare entity in adult …

[HTML][HTML] Local recurrence after minimally invasive curettage for primary giant cell tumor of bone with perioperative bisphosphonate is comparable to open curettage …

HW Lau, KC Wong, WK Chiu, SM Kumta - Arthroscopy, Sports Medicine …, 2021 - Elsevier
Purpose To compare the long-term oncological outcome of minimally invasive curettage
(MIC) with conventional open curettage (OC). Methods We studied patients with primary …

[PDF][PDF] Treatment of Recurrent Giant Cell Tumor of Bones: A Systematic Review. Cancers 2023, 15, 3287

C Pitsilos, P Givissis, P Papadopoulos, B Chalidis - 2023 - academia.edu
The giant cell tumor of bones (GCTB) is a benign bone tumor with high postoperative
recurrence potential. No specific treatment protocol has been developed to date in case of …

골내시경으로치료한원위부비골의거대세포종

황역구, 박종훈 - Journal of the Korean Orthopaedic Association, 2024 - jkoa.org
초록 뼈의 거대세포종은 국소적으로 공격적인 성향이며, 간혹 폐로 혈행성 전이를 일으키는
양성 종양으로 모든 원발성 골 종양의 약 6% 정도이다. 또한 족부 족관절 부위에서 발생은 4 …